LearnGlossaryMarketStocksSuperinvestorsSign in

NMTC

NeuroOne Medical Technologies Corporation

Healthcare · $10M market cap

Verdict

We can't put a fair value on NMTC right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-26.8% a year✗
Sales growth59.8% a year✓
Free cash flow growth—?
Return on invested capital-29.1%✗

Follow NMTC

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Aug 27, 2026: 1 open-market purchase worth $67K and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Purchases

Wambeke David J.

Chief Business Officer · 2026-08-27

Bought

$67K

Other filings

Wambeke David J.

Chief Business Officer · 2026-08-28

Award

$62K

About NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works